GOVERNMENT APPROVAL OR REGISTRATION. 21.1 If this Agreement or any associated transaction is required by the law of any nation to be either approved or registered with any governmental agency, LICENSEE will assume all legal obligations to do so. LICENSEE will notify REGENTS if it becomes aware that this Agreement is subject to a United States or foreign government reporting or approval requirement. LICENSEE will make all necessary filings and pay all costs including fees, penalties, and all other out-of-pocket costs associated with such reporting or approval process. 4D Molecular Therapeutics LLC Exclusive License UC Case No.: B03-104 Confidential [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
Appears in 2 contracts
Samples: Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.), Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.)
GOVERNMENT APPROVAL OR REGISTRATION. 21.1 If this Agreement or any associated transaction is required by the law of any nation to be either approved or registered with any governmental agency, LICENSEE will assume all legal obligations to do so. LICENSEE will notify REGENTS if it becomes aware that this Agreement is subject to a United States or foreign government reporting or approval requirement. LICENSEE will make all necessary filings and pay all costs including fees, penalties, and all other out-of-pocket costs associated with such reporting or approval process. 4D Molecular Therapeutics LLC Exclusive License UC Case No.: B03B13-104 135 Confidential [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
Appears in 2 contracts
Samples: Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.), Exclusive License and Bailment Agreement (4D Molecular Therapeutics Inc.)